Literature DB >> 19411572

A systematic review of recent asthma symptom surveys in Iranian children.

A Entezari1, Y Mehrabi, M Varesvazirian, Z Pourpak, M Moin.   

Abstract

Asthma is the most prevalent chronic disease in children. To quantify the national prevalence of asthma symptoms in Iranian children, we conducted a systematic review and meta-analysis. After internet and hand searching for population-based prevalence estimates published from 1998 to 2003 from 142 articles, dissertations and reports of research projects, 19 of them were selected. All the selected studies on children had been performed by the International Study of Asthma and Allergies in Childhood (ISAAC) protocol. We analyzed the data using NCSS software. In the included 19 studies, 61,067 children in different age groups had been examined by the ISAAC protocol. The lowest prevalence of asthma symptoms was 2.7% in Kerman and the highest was 35.4% in Tehran (capital of Iran). Overall prevalence of asthma symptoms at a national level was estimated as 13.14% (95% CI: 9.97-16.30%). Based on this study, the prevalence of asthma symptoms in Iran is higher than that estimated in the international reports. This information can be used to help prioritize asthma prevention and control within the range of Iranian public health concerns.

Entities:  

Mesh:

Year:  2009        PMID: 19411572     DOI: 10.1177/1479972309103884

Source DB:  PubMed          Journal:  Chron Respir Dis        ISSN: 1479-9723            Impact factor:   2.444


  14 in total

1.  Prevalence of Iron Deficiency Anemia among Iranian Pregnant Women; a Systematic Review and Meta-analysis.

Authors:  Barooti Esmat; Rezazadehkermani Mohammad; Sadeghirad Behnam; Motaghipisheh Shahrzad; Tayeri Soodabeh; Arabi Minoo; Salahi Saman; Haghdoost Ali-Akbar
Journal:  J Reprod Infertil       Date:  2010-04

Review 2.  Gene susceptibility in Iranian asthmatic patients: a narrative review.

Authors:  R Alizadeh-Navaei; A Rafiei; A Hedayatizadeh-Omran; I Mohammadzadeh; M Arabi
Journal:  Ann Med Health Sci Res       Date:  2014-11

3.  Association of ADAM33 gene polymorphisms with allergic asthma.

Authors:  Mohammad Reza Zand Karimi; Reza Faridhosseini; Mohammad Reza Abbaszadegan; Farrahzad Jabbari Azad; Afshin Shirkani; Anali Riyahi; Mehdi Montazar; Mehran Gholamin
Journal:  Iran J Basic Med Sci       Date:  2014-09       Impact factor: 2.699

4.  Level of Agreement between Children with Asthma and their Parents on Quality of Life.

Authors:  Maryam Khoshkhui; Peyman Jafari; Maryam Afrasiabi; Marzieh Orooj; Sara Kashef
Journal:  Iran J Med Sci       Date:  2016-03

5.  Asthma prevalence in Iranian guidance school children, a descriptive meta-analysis.

Authors:  Jafar Hassanzadeh; Abolfazl Mohammadbeigi; Ali Mousavizadeh; Mojtaba Akbari
Journal:  J Res Med Sci       Date:  2012-03       Impact factor: 1.852

6.  Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies.

Authors:  Mohammad Ali Rezvanfar; Abbas Kebriaeezadeh; Mostafa Moein; Shekoufeh Nikfar; Zahra Gharibnaseri; Akbar Abdollahi-Asl
Journal:  J Res Pharm Pract       Date:  2013-10

7.  Effect of Family Empowerment on the Quality of life of School-Aged Children with Asthma.

Authors:  Zahra Payrovee; Zahra Kashaninia; Seyed Alireza Mahdaviani; Pouria Rezasoltani
Journal:  Tanaffos       Date:  2014

8.  Impact of maternal mental health on pediatric asthma control.

Authors:  Zeinab Ghaempanah; Mohammad Reza Fazlollahi; Ahmad Ali Noorbala; Masoud Movahedi; Anoshiravan Kazemnejad; Zahra Pourpak; Mostafa Moin
Journal:  Tanaffos       Date:  2013

9.  Reliability and Validity of the Iranian Version of Nijmegen Questionnaire in Iranians with Asthma.

Authors:  Majid Ravanbakhsh; Moslem Nargesi; Hanieh Raji; Maryam Haddadzadeh Shoushtari
Journal:  Tanaffos       Date:  2015

10.  Atopic Manifestations: Dermatitis, Allergic Rhinitis and Asthma in Patients With Hypogammaglobulinemia.

Authors:  Minoo Dadkhah; Asghar Aghamohammadi; Masoud Movahedi; Mohammad Gharagozlou
Journal:  Iran J Pediatr       Date:  2015-10-06       Impact factor: 0.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.